Acadia Q3 revenue $666.7M (+13.5% YoY); adj. EPS $0.86; narrows FY2022 guidance

Acadia Healthcare Company, Inc.

2022-Q3 EPS reported $2.31 revenue$1,935,104,000

Revenue $666.7M, +13.5% YoY; same facility revenue +10.2% on 6.9% revenue per patient day and 3.1% patient day growth.
Net income $71.1M ($0.78 diluted EPS); adjusted EPS $0.86 ($0.80 excl. Provider Relief Fund income).
Adjusted EBITDA $162.8M (incl. $7.7M PRF); excl. PRF $155.1M.
FY2022 guidance narrowed: revenue $2.58-2.60B; adj. EPS $3.13-3.23 (incl. PRF) / $3.00-3.10 (excl.).
Cash $93.4M, $515M revolver available; net leverage ~2.1x; repaid Medicare advances and payroll tax deferrals.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Acadia Healthcare Company, Inc. reported third quarter ended September 30, 2022 results: revenue $666.7 million, net income $71.1 million, EPS $0.78 per diluted share.

Period: third quarter ended September 30, 2022
Revenue: $666.7 million
Net income: $71.1 million
EPS: $0.78 per diluted share
Result: reported results

Exact text from the filing

The Company reported revenue of $666.7 million for the third quarter of 2022, compared with $587.6 million for the third quarter of 2021.

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-22-001454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.